OYSTOyster Point Pharma, Inc.

Nasdaq oysterpointrx.com


$ 11.16 $ 0.02 (0.18 %)    

Friday, 30-Dec-2022 15:57:57 EST
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 11.17
$ 10.91 x 100
$ 11.36 x 100
-- - --
$ 3.46 - $ 19.00
2,088,283
na
299.7M
$ 0.43
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2022 09-30-2022 10-Q
2 08-11-2022 06-30-2022 10-Q
3 05-05-2022 03-31-2022 10-Q
4 02-24-2022 12-31-2021 10-K
5 11-04-2021 09-30-2021 10-Q
6 08-05-2021 06-30-2021 10-Q
7 05-06-2021 03-31-2021 10-Q
8 02-18-2021 12-31-2020 10-K
9 11-05-2020 09-30-2020 10-Q
10 08-05-2020 06-30-2020 10-Q
11 05-11-2020 03-31-2020 10-Q
12 02-27-2020 12-31-2019 10-K
13 12-03-2019 09-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 health-care-becomes-most-overweighted-sector-as-hedge-funds-crowd-into-magnificent-7

Goldman Sachs' Hedge Fund Trend Monitor highlights concentration in mega-caps, with optimism in AI and health care.

 oyster-point-pharma-q3-eps-137-beats-153-estimate-sales-559m-miss-693m-estimate

Oyster Point Pharma (NASDAQ:OYST) reported quarterly losses of $(1.37) per share which beat the analyst consensus estimate of $...

 earnings-scheduled-for-november-10-2022

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.

 benzingas-top-ratings-upgrades-downgrades-for-november-8-2022

Upgrades

 chardan-capital-downgrades-oyster-point-pharma-to-neutral-lowers-price-target-to-13

Chardan Capital analyst Daniil Gataulin downgrades Oyster Point Pharma (NASDAQ:OYST) from Buy to Neutral and lowers the pric...

 cigna-to-335-plus-this-analyst-slashes-pt-on-six-flags-entertainment-by-25

  SVB Leerink raised the price target on Cigna Corporation (NYSE: CI) from $305 to $335. Cigna shares rose 0.7% to close at ...

 why-huadi-international-group-shares-dipped-around-91-here-are-79-biggest-movers-from-yesterday

Gainers

 piper-sandler-downgrades-oyster-point-pharma-to-neutral-lowers-price-target-to-11

Piper Sandler analyst Joseph Catanzaro downgrades Oyster Point Pharma (NASDAQ:OYST) from Overweight to Neutral and lowers th...

 spirit-aerosystems-oyster-point-pharma-snap-and-other-big-gainers-from-monday

U.S. stocks closed higher on Monday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recor...

 dow-surges-400-points-crude-oil-down-1

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 400 points on Monday.

 12-health-care-stocks-moving-in-mondays-intraday-session

Gainers

 analyzing-oyster-point-pharmas-short-interest

Oyster Point Pharma's (NASDAQ:OYST) short percent of float has fallen 17.95% since its last report. The company recently re...

 why-oyster-point-pharma-shares-are-trading-higher-by-around-40-here-are-49-stocks-moving-in-mondays-mid-day-session

Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.

 dow-jumps-over-200-points-verve-therapeutics-shares-plummet

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Monday.

 us-stocks-mixed-dow-rises-over-50-points

U.S. stocks traded mixed this morning, with the Dow Jones gaining over 50 points on Monday.

 10-short-squeeze-candidates-that-may-soar-minerva-neurosciences-faze-getty-images-and-more

Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge m...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION